Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -141.90% is 21% below its 5-year average of -117.34%, near the high end of its 5-year range (-538.91%–-35.96%).
As of the fiscal period ended Tuesday, June 30, 2026. 40.72% above its 12-month average of -239.36%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -141.90%.
RETURN ON EQUITY (ROE)
-141.90%
RETURN ON EQUITY (ROE) AVG TTM
-239.36%
RETURN ON EQUITY (ROE) AVG 3Y
-153.07%
RETURN ON EQUITY (ROE) AVG 5Y
-117.34%
RETURN ON EQUITY (ROE) AVG 10Y
-114.22%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+40.72%
CURRENT VS 3Y AVG
+7.30%
CURRENT VS 5Y AVG
-20.93%
CURRENT VS 10Y AVG
-24.23%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-39.44%
median of 550 covered companies
CURRENT VS SECTOR MEDIAN
-259.82%
vs the sector median at left
IceCure Medical Ltd
Market Cap
$3.28M
Return on Equity (ROE)
-141.90%
TTM Avg
-239.36%
3Y Avg
-153.07%
5Y Avg
-117.34%
Market Cap
$3.25M
Return on Equity (ROE)
-282.13%
TTM Avg
-313.25%
3Y Avg
-153.55%
5Y Avg
-153.55%
Market Cap
$3.27M
Return on Equity (ROE)
-133.43%
TTM Avg
-203.84%
3Y Avg
-174.81%
5Y Avg
-140.61%
Market Cap
$3.21M
Return on Equity (ROE)
120.45%
TTM Avg
927.43%
3Y Avg
433.61%
5Y Avg
340.10%
Market Cap
$3.40M
Return on Equity (ROE)
-89.85%
TTM Avg
30.83%
3Y Avg
-183.24%
5Y Avg
-146.59%
Market Cap
$3.46M
Return on Equity (ROE)
N/A
TTM Avg
5741.84%
3Y Avg
2797.55%
5Y Avg
1847.94%
Market Cap
$3.49M
Return on Equity (ROE)
-40.20%
TTM Avg
193.27%
3Y Avg
-10433.46%
5Y Avg
-6975.64%
Market Cap
$3.04M
Return on Equity (ROE)
-365.43%
TTM Avg
-2048.73%
3Y Avg
-1082.52%
5Y Avg
-614.77%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IceCure Medical Ltd (ICCM) | $3.28M | -141.90% | -239.36% | -153.07% | -117.34% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.25M | -282.13% | -313.25% | -153.55% | -153.55% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | -133.43% | -203.84% | -174.81% | -140.61% |
| MBody AI Ltd. (MBAI)vs › | $3.21M | 120.45% | 927.43% | 433.61% | 340.10% |
| Moolec Science S.A. (MLEC)vs › | $3.40M | -89.85% | 30.83% | -183.24% | -146.59% |
| Evogene Ltd. (EVGN)vs › | $3.46M | N/A | 5741.84% | 2797.55% | 1847.94% |
| Eocene Ltd. (EOCN)vs › | $3.47M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -40.20% | 193.27% | -10433.46% | -6975.64% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | -365.43% | -2048.73% | -1082.52% | -614.77% |
| Nexalin Technology, Inc. (NXL)vs › | $3.58M | -591.60% | -213.16% | -150.57% | -4.48% |
ROE
-141.9%
ROA
-95.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -141.90% |
| 2026-03-31 | -185.34% |
| 2025-12-31 | -166.36% |
| 2025-09-30 | -164.30% |
| 2025-06-30 | -538.91% |
| 2025-03-31 | -254.95% |
| 2024-12-31 | -221.97% |
| 2024-09-30 | -137.51% |
| 2024-06-30 | -128.98% |
| 2024-03-31 | -124.55% |
| 2023-12-31 | -120.46% |
| 2023-09-30 | -105.56% |
| 2023-06-30 | -84.97% |
| 2023-03-31 | -74.05% |
| 2022-12-31 | -66.78% |
| 2022-09-30 | -105.89% |
| 2022-06-30 | -79.55% |
| 2022-03-31 | -56.49% |
| 2021-12-31 | -36.71% |
| 2021-09-30 | -54.42% |
| 2021-06-30 | -35.96% |
| 2021-03-31 | -22.78% |
| 2020-12-31 | -66.04% |
| 2020-09-30 | -116.82% |
| 2020-06-30 | -376.71% |
| 2020-03-31 | -430.14% |
| 2019-12-31 | -178.03% |
| 2019-09-30 | -50.21% |
| 2019-06-30 | -196.40% |
| 2019-03-31 | -50.38% |
| 2018-12-31 | -108.79% |
| 2018-09-30 | -20.86% |
| 2018-06-30 | -62.80% |
| 2018-03-31 | -16.19% |
| 2017-09-30 | -209.71% |
| 2017-06-30 | -253.13% |
| 2017-03-31 | -76.09% |
| 2016-12-31 | -157.35% |
| 2016-09-30 | -113.31% |
| 2016-06-30 | -180.55% |
| 2016-03-31 | -133.07% |
| 2015-12-31 | -97.43% |
| 2015-09-30 | -88.81% |
| 2015-06-30 | -76.46% |
| 2015-03-31 | -77.37% |
| 2014-12-31 | -71.07% |
| 2014-09-30 | -76.04% |
| 2014-06-30 | -46.74% |
| 2014-03-31 | -35.03% |
| 2013-12-31 | -26.81% |
| 2013-09-30 | -22.13% |
| 2013-06-30 | -63.52% |
